Skip to main content

Gelesis Holdings, Inc.

GLSHDelisted Apr 26, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001805087

Gelesis Holdings, Inc. was delisted on Apr 26, 2023; its insiders filed their last Form 4 on Sep 21, 2023; 39 institutions reported holding it in 13F filings for Q1 2023, worth $3.55M in total; no superinvestor held it.

Holders of 5% or more of GLSH

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Gelesis Holdings, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Gelesis Holdings, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

29 Schedule 13D and 13G filings on Gelesis Holdings, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on GLSH
Filed (ET)FilerFormStakeChangeEvent dateFiling
Oct 16, 2023PureTech Health LLC13D/AOld format–––SEC
Sep 21, 2023PureTech Health LLC13D/AOld format–––SEC
Jun 29, 2023PureTech Health LLC13D/AOld format–––SEC
Jun 13, 2023PureTech Health LLC13D/AOld format–––SEC
May 30, 2023PureTech Health LLC13D/AOld format–––SEC
May 2, 2023PureTech Health LLC13D/AOld format–––SEC
Apr 20, 2023PureTech Health LLC13D/AOld format–––SEC
Apr 4, 2023PureTech Health LLC13D/AOld format–––SEC
Feb 23, 2023PureTech Health LLC13D/AOld format–––SEC
Feb 14, 2023Pacific Investment Management Co LLC13G/AOld format–––SEC
Feb 13, 2023Periscope Capital Inc.13G/AOld format–––SEC
Feb 10, 2023Aristeia Capital LLC13G/AOld format–––SEC
Dec 30, 2022SSD2, LLC13DOld format–––SEC
Aug 4, 2022PureTech Health LLC13D/AOld format–––SEC
Jul 20, 2022CMS Medical Venture Investment (HK) Ltd13GOld format–New–SEC
Feb 22, 2022Capstar Sponsor Group, LLC13GOld format–New–SEC
Feb 14, 2022Periscope Capital Inc.13GOld format–New–SEC
Feb 14, 2022Aristeia Capital LLC13GOld format–New–SEC
Feb 14, 2022Citadel Advisors LLC13G/AOld format–––SEC
Feb 14, 2022Glazer Capital, LLC13G/AOld format–––SEC
Feb 14, 2022Marshall Wace, LLP13GOld format–New–SEC
Feb 10, 2022Pacific Investment Management Co LLC13GOld format–New–SEC
Feb 10, 2022Morgan Stanley13G/AOld format–––SEC
Feb 10, 2022Morgan Stanley13GOld format–New–SEC
Jan 21, 2022SSD2, LLC13GOld format–New–SEC
Jan 21, 2022PureTech Health LLC13DOld format–New–SEC
Jan 21, 2022HPSO SPV Ltd13DOld format–New–SEC
Sep 20, 2021Citadel Advisors LLC13GOld format–New–SEC
Feb 16, 2021Glazer Capital, LLC13GOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Gelesis Holdings, Inc. shares.

No Form 144 notices for Gelesis Holdings, Inc. are on file.